OCUL
OCULAR THERAPEUTIX, INC
NASDAQ · Healthcare · Biotechnology · US
$6.40
+1.82%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 19.53x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.70x
- Price / sales
- 27.02x
- Price / cash flow
- -5.90x
Enterprise value
- Enterprise value
- $887.2M
- EV / sales
- 17.04x
- EV / EBITDA
- -3.12x
- EV / EBIT
- -2.83x
- Market cap
- $1.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026